<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neuropathol Exp Neurol</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Neuropathol. Exp. Neurol</journal-id>
<journal-id journal-id-type="publisher-id">jnen</journal-id>
<journal-title-group>
<journal-title>Journal of Neuropathology and Experimental Neurology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-3069</issn>
<issn pub-type="epub">1554-6578</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30990880</article-id>
<article-id pub-id-type="pmc">6467199</article-id>
<article-id pub-id-type="doi">10.1093/jnen/nlz023</article-id>
<article-id pub-id-type="publisher-id">nlz023</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Peri-Infarct Upregulation of the Oxytocin Receptor in Vascular Dementia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>McKay</surname>
<given-names>Erin C</given-names>
</name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="nlz023-aff1">1</xref>
<xref ref-type="aff" rid="nlz023-aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Beck</surname>
<given-names>John S</given-names>
</name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="nlz023-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Khoo</surname>
<given-names>Sok Kean</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="nlz023-aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dykema</surname>
<given-names>Karl J</given-names>
</name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="nlz023-aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cottingham</surname>
<given-names>Sandra L</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="nlz023-aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Winn</surname>
<given-names>Mary E</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="nlz023-aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Paulson</surname>
<given-names>Henry L</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="nlz023-aff6">6</xref>
<xref ref-type="aff" rid="nlz023-aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lieberman</surname>
<given-names>Andrew P</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="nlz023-aff7">7</xref>
<xref ref-type="aff" rid="nlz023-aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Counts</surname>
<given-names>Scott E</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="nlz023-aff1">1</xref>
<xref ref-type="aff" rid="nlz023-aff2">2</xref>
<xref ref-type="aff" rid="nlz023-aff8">8</xref>
<xref ref-type="aff" rid="nlz023-aff9">9</xref>
<xref ref-type="aff" rid="nlz023-aff10">10</xref>
<xref ref-type="corresp" rid="nlz023-cor1"></xref>
<!--<email>scott.counts@hc.msu.edu</email>-->
</contrib>
</contrib-group>
<aff id="nlz023-aff1"><label>1</label>Department of Translational Science and Molecular Medicine, Michigan State University, Grand Rapids, Michigan</aff>
<aff id="nlz023-aff2"><label>2</label>Neuroscience Program, Michigan State University, East Lansing, Michigan</aff>
<aff id="nlz023-aff3"><label>3</label>Department of Cell and Molecular Biology, Grand Valley State University, Grand Rapids, Michigan</aff>
<aff id="nlz023-aff4"><label>4</label>Bioinformatics and Biostatistics Core, Van Andel Research Institute, Grand Rapids, Michigan</aff>
<aff id="nlz023-aff5"><label>5</label>Department of Pathology, Spectrum Health and Helen DeVos Children’s Hospital, Grand Rapids, Michigan</aff>
<aff id="nlz023-aff6"><label>6</label>Department of Neurology, University of Michigan, Ann Arbor, Michigan</aff>
<aff id="nlz023-aff7"><label>7</label>Department of Pathology, University of Michigan, Ann Arbor, Michigan</aff>
<aff id="nlz023-aff8"><label>8</label>Michigan Alzheimer’s Disease Core Center, Ann Arbor, Michigan</aff>
<aff id="nlz023-aff9"><label>9</label>Department of Family Medicine, Michigan State University, Grand Rapids, Michigan</aff>
<aff id="nlz023-aff10"><label>10</label>Hauenstein Neurosciences Center, Mercy Health Saint Mary’s Hospital, Grand Rapids, Michigan</aff>
<author-notes>
<corresp id="nlz023-cor1">Send correspondence to: Scott E. Counts, PhD, Department of Translational Science and Molecular Medicine, Michigan State University, 400 Monroe Ave. NW, Grand Rapids, MI 49503; E-mail: <email>scott.counts@hc.msu.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date iso-8601-date="2019-04-11" pub-type="epub">
<day>11</day>
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>5</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>78</volume>
<issue>5</issue>
<fpage>436</fpage>
<lpage>452</lpage>
<permissions>
<copyright-statement>© 2019 American Association of Neuropathologists, Inc. All rights reserved.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="publisher-standard" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">
<license-p>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model</ext-link>)</license-p>
</license>
</permissions>
<self-uri xlink:href="nlz023.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>Vascular dementia (VaD) is cognitive decline linked to reduced cerebral blood perfusion, yet there are few therapeutic options to protect cognitive function following cerebrovascular accidents. The purpose of this study was to profile gene expression changes unique to VaD to identify and characterize disease relevant changes that could offer clues for future therapeutic direction. Microarray-based profiling and validation studies of postmortem frontal cortex samples from VaD, Alzheimer disease, and age-matched control subjects revealed that the oxytocin receptor (OXTR) was strongly and differentially upregulated in VaD. Further characterization in fixed tissue from the same cases showed that OXTR upregulation occurs de novo around and within microinfarcts in peri-infarct reactive astrocytes as well as within vascular profiles, likely on microvascular endothelial cells. These results indicate that increased OXTR expression in peri-infarct regions may be a specific response to microvascular insults. Given the established OXTR signaling cascades that elicit antioxidant, anti-inflammatory, and pro-angiogenic responses, the present findings suggest that de novo OXTR expression in the peri-infarct space is a tissue-protective response by astroglial and vascular cells in the wake of ischemic damage that could be exploited as a therapeutic option for the preservation of cognition following cerebrovascular insults.</p>
</abstract>
<kwd-group kwd-group-type="author">
<kwd>Alzheimer disease</kwd>
<kwd>Astrocvytes</kwd>
<kwd>Microinfarcts</kwd>
<kwd>Microvascular endothelial cells</kwd>
<kwd>Oxytocin receptor</kwd>
<kwd>Vascular dementia</kwd>
</kwd-group>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">NIH</named-content>
<named-content content-type="funder-identifier">10.13039/100000002</named-content>
</funding-source>
<award-id>AG014449</award-id>
<award-id>AG053581</award-id>
<award-id>AG053760</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">Saint Mary's Foundation</named-content>
<named-content content-type="funder-identifier">10.13039/100012205</named-content>
</funding-source>
</award-group>
</funding-group>
<counts>
<page-count count="17"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>